The Swoop portable MRI system showed 92% agreement with traditional MRI scans and was four times more likely to be chosen by ...

NASHVILLE, Tennessee — A second-generation anti-CD40L monoclonal antibody suppresses multiple sclerosis (MS) disease activity on MRI to an uncommonly high degree, new trial data suggested. Researchers ...

There may be two distinct subtypes of multiple sclerosis, according to a new study led by scientists at University College London (UCL). The finding, if validated, could help doctors provide more ...

Background Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and multiple sclerosis (MS) have both ...

Radiomics offers improved assessment of spinal cord pathology in MS, surpassing conventional MRI in precision and sensitivity. A study identified 12 significant radiomic features, with four ...

There is no single test that unequivocally detects MS. When faced with a patient whose symptoms, neurological exam results, and medical history suggest MS, physicians use a variety of tools to look ...

"In terms of association with climate, our results suggest a relationship between enhancing lesions and tropical nights, a variable indicating extreme temperatures, which had not been previously ...

The Elliot's Neurological Specialties clinic combines medical treatments to slow MS progression with holistic approaches to ...

High-dose vitamin D reduced disease activity in early MS and CIS compared with placebo. Patients taking vitamin D had a longer time to disease activity: 432 days versus 224 days. No severe adverse ...

BUFFALO, N.Y. – For people with multiple sclerosis (MS), hearing a doctor tell them they are experiencing brain atrophy—an important, predictive biomarker of MS disease progression—can trigger ...